Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Diabetes Publish Ahead of Print published online ahead of print October 10, 2007
DOI: 10.2337/db06-1700

This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
db06-1700v1
57/1/113    most recent
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tritt, M.
Right arrow Articles by Piccirillo, C.A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tritt, M.
Right arrow Articles by Piccirillo, C.A.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Original Research

Functional waning of naturally-occurring CD4+ regulatory T cells contributes to the onset of autoimmune diabetes.

M. Tritt, E. Sgouroudis, E. d'Hennezel, A. Albanese, and C.A. Piccirillo

Department of Microbiology and Immunology, and McGill Center for the Study of Host Resistance., McGill University, Montreal, QC, Canada, H3A 2B4

Objective: In this study, we asked whether a possible quantitative or qualitative deficiency in naturally-occurring Foxp3+CD4+ regulatory T cells (nTreg), which display potent inhibitory effects on T cell functions in vitro and in vivo, may predispose to the development of T1D.

Research Design and Methods: We assessed the frequency and function of Foxp3+ nTreg cells in primary and secondary lymphoid tissues in the NOD animal model of type 1 diabetes.

Results: We show that the cellular frequency of Foxp3+ nTreg cells in primary and secondary lymphoid tissues is stable and does not decline relative to T1D-resistant mice. We show that thymic and peripheral CD4+CD25+ T cells are fully functional in vivo. We also examined the functional impact of CD4+Foxp3+ nTreg cells on the development of autoimmune diabetes, and demonstrate that nTreg cells do not affect the initial priming or expansion of antigen-specific diabetogenic T cells but impact their differentiation in pancreatic lymph nodes (pancLN). Moreover, CD4+Foxp3+ nTreg cells also regulate later events of diabetogenesis by preferentially localizing in the pancreatic environment where they suppress the accumulation and function of effector T cells (Teff). Finally, we show that the nTreg cell functional potency and intra-pancreatic proliferative potential declines with age, in turn augmenting diabetogenic responses and disease susceptibility.

Conclusion: This study demonstrates that Foxp3-expressing nTreg cells in NOD mice regulate diabetogenesis, but temporal alterations in nTreg cell function promote immune dysregulation, and the onset of spontaneous autoimmunity.


Correspondence: Ciro.piccirillo{at}mcgill.ca


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2007 by the American Diabetes Association.